We could not find any results for:
Make sure your spelling is correct or try broadening your search.
GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence applic ...
GSK PLC 24 April 2024 Issued: 24 April 2024, London UK US FDA accepts for priority review GSK's application for an expanded indication of Jemperli (dostarlimab) plus chemotherapy to...
GSK PLC 19 April 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...
GSK PLC 17 April 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief Executive...
GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a for ...
GSK PLC 17 April 2024 Issued: 17 April 2024, London UK EAGLE-1 phase III data show potential for gepotidacin as a new oral treatment option for uncomplicated urogenital gonorrhoea (GC...
GSK PLC 17 April 2024 Issued: 17 April 2024, London UK New long-term data show Shingrix continues to provide high protection against shingles in adults aged 50 and over for more than a...
GSK PLC 16 April 2024 The following amendment has been made to the 'Director/PDMR Shareholding' announcement released on 15 April 2024 at 15:30 under RNS No 6703K: - A typographical...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions